Literature DB >> 7262983

Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake.

A W Cowley, W C Cushman, E W Quillen, M M Skelton, H G Langford.   

Abstract

The relationship of arterial pressure (AP) to plasma arginine vasopressin (AVP) and sodium (Na) intake was determined in untreated essential hypertensive (H) and normotensive (N) subjects. The AP of H subjects averaged 147/101 mm Hg and that of N subjects, 124/79 mm Hg. Plasma AVP was elevated significantly in H subjects, averaging 8.5 pg/ml compared to 4.7 pg/ml in N subjects. Multivariant regression analysis yielded a significant correlation (r2 = 0.34) between diastolic pressure, urine Na concentration, and changes in plasma AVP. Plasma Na of H subjects averaged 2.0 mEq/liter less and urine Na concentration 22 mEq/liter less than in N subjects. Sodium intake appeared to have no influence on the plasma AVP of N subjects, but H subjects excreting Na in excess of 250 mEq/day averaged a plasma AVP twice as high as that in H subjects excreting less than 150 mEq/day. In H subjects, the influence of Na intake appeared to be related to age. In subjects less than 50 years of age, Na intake did not appear to influence chronic levels of plasma AVP, while in subjects older than 50 years who were excreting Na in excess of 250 mEq/day, plasma AVP levels were twice (13.5 pg/ml) those observed in hypertensives of the same age excreting less than 150 mEq/ day (6.5 pg/ml). The data indicate that plasma AVP tends to be elevated in moderate essential hypertension. Reduced concentrating ability of the kidneys of these subjects is suggested by decreased urine Na concentrations despite elevated plasma AVP. The observed increases of plasma AVP could be exerting a direct influence on extra- and intravascular volumes by renal and systemic vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262983     DOI: 10.1161/01.hyp.3.3_pt_2.i93

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Osmotic homeostasis.

Authors:  John Danziger; Mark L Zeidel
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-30       Impact factor: 8.237

2.  Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor.

Authors:  J Fukuzawa; T Haneda; K Kikuchi
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  [Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].

Authors:  C Ertmer; A W Sielenkämper; H van Aken; H-G Bone; M Westphal
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

4.  Vasopresin and human hypertension.

Authors:  Alberto Del Bo
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

5.  Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension.

Authors:  E B Pedersen; H Danielsen; E S Spencer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  [Cardiovascular effect of the antidiuretic hormone arginine vasopressin].

Authors:  W Rascher
Journal:  Klin Wochenschr       Date:  1985-10-01

Review 7.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

8.  Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.

Authors:  Alexander R Mackie; Lioubov I Brueggemann; Kyle K Henderson; Aaron J Shiels; Leanne L Cribbs; Karie E Scrogin; Kenneth L Byron
Journal:  J Pharmacol Exp Ther       Date:  2008-02-13       Impact factor: 4.030

9.  Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.

Authors:  T J Ebert; A W Cowley; M Skelton
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Regulation of vasopressin release in moderately severe essential hypertension.

Authors:  A Del Bo; M Marabini; A Morganti; A Zanchetti
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.